To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

NCT06376474 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Hemay005

Sponsor

Ganzhou Hemay Pharmaceutical Co., Ltd